Australia markets closed

Treace Medical Concepts, Inc. (TMCI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.88-0.01 (-0.13%)
At close: 04:00PM EDT
7.51 -0.37 (-4.70%)
After hours: 06:34PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 488.62M
Enterprise value 448.73M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.48
Price/book (mrq)3.87
Enterprise value/revenue 2.29
Enterprise value/EBITDA -40.95

Trading information

Stock price history

Beta (5Y monthly) 0.23
52-week change 3-64.44%
S&P500 52-week change 320.87%
52-week high 324.00
52-week low 33.92
50-day moving average 36.20
200-day moving average 310.19

Share statistics

Avg vol (3-month) 31.46M
Avg vol (10-day) 31.15M
Shares outstanding 562.01M
Implied shares outstanding 662.01M
Float 843.25M
% held by insiders 127.83%
% held by institutions 168.27%
Shares short (28 June 2024) 43.95M
Short ratio (28 June 2024) 43.18
Short % of float (28 June 2024) 48.15%
Short % of shares outstanding (28 June 2024) 46.36%
Shares short (prior month 31 May 2024) 45.08M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin -27.93%
Operating margin (ttm)-37.01%

Management effectiveness

Return on assets (ttm)-14.33%
Return on equity (ttm)-38.55%

Income statement

Revenue (ttm)196.03M
Revenue per share (ttm)3.18
Quarterly revenue growth (yoy)21.10%
Gross profit (ttm)N/A
EBITDA -50.54M
Net income avi to common (ttm)-54.75M
Diluted EPS (ttm)-0.88
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)110.01M
Total cash per share (mrq)1.77
Total debt (mrq)70.11M
Total debt/equity (mrq)55.47%
Current ratio (mrq)3.98
Book value per share (mrq)2.04

Cash flow statement

Operating cash flow (ttm)-24.54M
Levered free cash flow (ttm)-25.39M